Stay informed on news and activities that affect the specialty by clicking on the links below.
CMS Releases Inpatient Proposed Rule, Expands CJR Model
Read The Full Article
AAPM&R Partners with MPW on Trigger Point Injections Proposed LCD
CMS Releases the Inpatient Rehabilitation Facility and Skilled Nursing Facility Prospective Payment System Proposed Rules for Fiscal Year 2027
MACs Release Draft Local Coverage Determinations for Botulinum Toxin Injections
AAPM&R Advocacy Helps Secure Bipartisan Congressional Support for Protecting Patient Access to Peripheral Nerve Blocks
AAPM&R Partners with MPW on Coverage Advocacy
AAPM&R Submits Comments on Adoption and Use of AI
Botulinum Toxin LCD – Reminder Regarding Spasticity Assessment
Incentives Restored for Advanced Alternative Payment Model Participants
Telehealth Flexibilities Extended Through December 31, 2027
CMS Releases List of Participants for Ambulatory Specialty Model – Low Back Pain
AAPM&R Advocacy Win! Medicare Contractors Finalize Comprehensive Botulinum Toxin Policy Aligned with Academy Advocacy Efforts and Valuable Member Input
Prepare for the CMS Cost Measure Field Testing Period: Parkinsonism Syndromes and Multiple Sclerosis
AAPM&R Opposes Announced CMS Expansion of the IRF Review Choice Demonstration to Texas and California in 2026
Brush Up on Coding with a New AAPM&R Resource
Following Productive Dialogue with AAPM&R, Novitas and First Coast Finalize Requested Updates to Botulinum Toxin Coding and Billing Article
AAPM&R Celebrates a Win in Durable Medical Equipment Local Coverage Determination
Assist AAPM&R with Improving MIPS Cost Measures and Feedback Reports
AAPM&R Collaborates with First Coast and Novitas Solutions on Coding Clarity for Botulinum Toxin LCDs
AAPM&R Welcomes Return of Medicare Telehealth Flexibilities: Continues Push for Fair Physician Payment